More from Marilynn Marchione
7 Actions Manufacturers Need to Take Now
This new industry playbook gives you the seven actions manufacturers need to take to move their companies in the right direction.
Apr 5th, 2021
Panel Urges Rejection of Experimental Alzheimer's Drug
Advisers concluded there wasn’t enough evidence that the drug slowed the disease.
Nov 9th, 2020
FDA Panel Reviews 1st New Alzheimer's Drug in 2 Decades
One of the biggest drug decisions in decades is looming.
Nov 6th, 2020
2nd COVID-19 Antibody Drug Study Has Setback
Independent monitors recommended halting enrollment of the most severely ill patients due to a potential safety problem.
Nov 2nd, 2020
FDA Approves First COVID-19 Drug
Remdesivir cut the time to recovery by an average of five days in a large study.
Oct 23rd, 2020
Antibody Drugs Are No Cure but Seem Promising for COVID-19
Eli Lilly and Regeneron have asked the Food and Drug Administration for emergency authorization.
Oct 9th, 2020
Lilly Seeks Emergency Use of Antibody Drug for COVID-19
Early results from a study that suggested the drug reduced symptoms, the amount of the virus, hospitalizations and ER visits.
Oct 7th, 2020
Drug Shows Promise in 1st Largely Minority COVID-19 Study
Tocilizumab, sold as Actemra and RoActemra, treats rheumatoid arthritis and other diseases.
Sep 21st, 2020
Antibody Drug May Cut COVID-19 Hospitalizations
Eli Lilly said the results are an encouraging “proof of principle” as it and other studies continue.
Sep 16th, 2020
Companies Test COVID-19 Antibody Drugs
With a vaccine still months off, companies are rushing to test what may be the next best thing.
Aug 12th, 2020
Study on Malaria Drug for Coronavirus Retracted
Independent reviewers were not able to verify information that’s been widely questioned by other scientists.
Jun 5th, 2020
Malaria Drug Fails to Prevent COVID-19 in Rigorous Study
Hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.
Jun 4th, 2020